Brief Information of the Cell Line and Protein
Cell Line ID: CL000025 , HEK-293T
Synonyms
Hek293T
HEK-293T
HEK 293T
HEK-293-T
HEK 293 T
293-T
293 T
293T
Human Embryonic Kidney 293T
293tsA1609neo
Category Transformed cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0063
Protein ID: PT01155 , Growth hormone secretagogue receptor type 1
Gene Name GHSR
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID Q92847
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000025  Protein ID: PT01155
 
Compound ID Compound Name Compound Formula
CP0475491
(2S)-2-acetamido-N-[(2S)-1-[[(1R)-1-[5-[(1R)-1-[(2-amino-2-methylpropanoyl)amino]-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide
   Show/Hide
C48H62N10O5
 2
1
EC50 = 0.8 nM
   TI
   LI
   LO
   TS
2
Ki = 30 nM
   TI
   LI
   LO
   TS
CP0280449
Ghrelin
   Show/Hide
C149H249N47O42
 2
1
EC50 = 1.51 nM
   TI
   LI
   LO
   TS
2
Ki = 1.28 nM
   TI
   LI
   LO
   TS
CP0440551
2-[[(2S,3S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-aminohexanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]acetic acid
   Show/Hide
C76H119N21O17
 6
1
EC50 = 2.5 nM
   TI
   LI
   LO
   TS
2
EC50 = 18 nM
   TI
   LI
   LO
   TS
3
EC50 = 76.4 nM
   TI
   LI
   LO
   TS
4
Kd = 34.67 nM
   TI
   LI
   LO
   TS
5
Kd = 89.13 nM
   TI
   LI
   LO
   TS
6
Ki = 3.66 nM
   TI
   LI
   LO
   TS
CP0544918
(2S)-N-[(1R)-1-[5-[(1R)-1-acetamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2,6-diaminohexanamide
   Show/Hide
C38H45N9O3
 2
1
EC50 = 4 nM
   TI
   LI
   LO
   TS
2
Ki = 2.5 nM
   TI
   LI
   LO
   TS
CP0848185
N-((R)-1-(5-((R)-1-((S)-2-((S)-2-acetamido-4-methylpentanamido)-4-methylpentanamido)-2-(1H-indol-3-yl)ethyl)-4-(4-methoxybenzyl)-4H-1,2,4-triazol-3-yl)-2-(1H-indol-3-yl)ethyl)piperidine-4-carboxamide
   Show/Hide
C50H64N10O5
 2
1
EC50 = 4.4 nM
   TI
   LI
   LO
   TS
2
Ki = 2 nM
   TI
   LI
   LO
   TS
CP0158770
(2S)-2,6-diamino-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-naphthalen-1-yl-1-oxopropan-2-yl]hexanamide
   Show/Hide
C51H67N9O6
 2
1
EC50 = 5.5 nM
   TI
   LI
   LO
   TS
2
Ki = 3.7 nM
   TI
   LI
   LO
   TS
CP0444785
(2S)-2,6-diamino-N-[(1R)-1-[5-[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]hexanamide
   Show/Hide
C37H43N9O3
 2
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
2
Ki = 8 nM
   TI
   LI
   LO
   TS
CP0169048
(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(1R,4S,7S,10R,13R,16R,19S,24R,27S,30S,33S,36S,39R,46S,49S,52S,55S)-30-(4-aminobutyl)-19-[[(2R)-2-[[(2R)-2-[[2-[[(2S,3S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-aminohexanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]acetyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]-16,27,33,36,52-pentakis(3-carbamimidamidopropyl)-4-(2-carboxyethyl)-10,13-bis(carboxymethyl)-46,49-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-55-(2-methylpropyl)-3,6,9,12,15,18,25,28,31,34,37,44,47,50,53,56-hexadecaoxo-21,22,41,42-tetrathia-2,5,8,11,14,17,26,29,32,35,38,45,48,51,54,57-hexadecazabicyclo[22.19.14]heptapentacontane-39-carbonyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]pentanedioic acid
   Show/Hide
C190H314N64O58S4
 6
1
EC50 = 16.6 nM
   TI
   LI
   LO
   TS
2
EC50 = 22.8 nM
   TI
   LI
   LO
   TS
3
EC50 = 27.7 nM
   TI
   LI
   LO
   TS
4
Kd = 1.479 nM
   TI
   LI
   LO
   TS
5
Kd = 10.23 nM
   TI
   LI
   LO
   TS
6
Ki = 1.26 nM
   TI
   LI
   LO
   TS
CP0510758
methyl 2-[[(1R)-1-[5-[(1R)-1-[[(2S)-2,6-diaminohexanoyl]amino]-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]carbamoyl]-4-methylpentanoate
   Show/Hide
C44H55N9O5
 2
1
EC50 = 20 nM
   TI
   LI
   LO
   TS
2
Ki = 17 nM
   TI
   LI
   LO
   TS
CP0358131
(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-aminohexanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxamide
   Show/Hide
C68H106N20O14
 2
1
EC50 = 46 nM
   TI
   LI
   LO
   TS
2
Ki = 2.7 nM
   TI
   LI
   LO
   TS
CP0302842
(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-aminohexanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-[(2S,3S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
   Show/Hide
C76H120N22O16
 2
1
EC50 = 48 nM
   TI
   LI
   LO
   TS
2
Ki = 3.05 nM
   TI
   LI
   LO
   TS
CP0904713
(S)-N-((R)-1-(5-((R)-1-((S)-2-((S)-2-acetamido-4-methylpentanamido)-4-methylpentanamido)-2-(1H-indol-3-yl)ethyl)-4-(4-methoxybenzyl)-4H-1,2,4-triazol-3-yl)-2-(1H-indol-3-yl)ethyl)morpholine-2-carboxamide
   Show/Hide
C49H62N10O6
 2
1
EC50 = 60 nM
   TI
   LI
   LO
   TS
2
Ki = 50 nM
   TI
   LI
   LO
   TS
CP0444784
(2S)-N-[(1R)-1-[5-[(1R)-1-[[(2S)-2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2,6-diaminohexanamide
   Show/Hide
C50H67N11O5
 2
1
EC50 = 70 nM
   TI
   LI
   LO
   TS
2
Ki = 110 nM
   TI
   LI
   LO
   TS
CP0428595
(2S)-2-acetamido-N-[(2S)-1-[[(1R)-1-[5-[(1R)-1-[(2-hydroxy-2-methylpropanoyl)amino]-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide
   Show/Hide
C48H61N9O6
 2
1
EC50 = 74 nM
   TI
   LI
   LO
   TS
2
Ki = 3 nM
   TI
   LI
   LO
   TS
CP0419821
methyl (2S)-2-[[2-[[(1R)-1-[5-[(1R)-1-[[(2S)-2,6-diaminohexanoyl]amino]-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]carbamoyl]-4-methylpentanoyl]amino]-4-methylpentanoate
   Show/Hide
C50H66N10O6
 2
1
EC50 = 82 nM
   TI
   LI
   LO
   TS
2
Ki = 220 nM
   TI
   LI
   LO
   TS
CP0422017
(2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide
   Show/Hide
C79H109N19O12
 2
1
EC50 = 98.7 nM
   TI
   LI
   LO
   TS
2
Ki = 76.7 nM
   TI
   LI
   LO
   TS
CP0379087
(2S)-2,6-diamino-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]hexanamide
   Show/Hide
C49H66N10O6
 2
1
EC50 = 100 nM
   TI
   LI
   LO
   TS
2
Ki = 255 nM
   TI
   LI
   LO
   TS
CP0535785
(2S)-1-[(2S,3R)-2-[[(2S)-2-aminohexanoyl]amino]-3-hydroxybutanoyl]-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide
   Show/Hide
C57H87N15O12
 2
1
EC50 = 134 nM
   TI
   LI
   LO
   TS
2
Ki = 3.4 nM
   TI
   LI
   LO
   TS
CP0447866
N-[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]-N'-[(1R)-1-[5-[(1R)-1-[[(2S)-2,6-diaminohexanoyl]amino]-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-(2-methylpropyl)propanediamide
   Show/Hide
C49H65N11O5
 2
1
EC50 = 170 nM
   TI
   LI
   LO
   TS
2
Ki = 210 nM
   TI
   LI
   LO
   TS
CP0435142
(2S)-1-[(2S,3R)-2-[[(2S)-2-aminohexanoyl]amino]-3-hydroxybutanoyl]-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide
   Show/Hide
C48H71N13O9
 2
1
EC50 = 368 nM
   TI
   LI
   LO
   TS
2
Ki = 6.45 nM
   TI
   LI
   LO
   TS
CP0360853
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-1-[(2S,3R)-2-[[(2S)-2-aminohexanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carboxamide
   Show/Hide
C41H59N11O7
 2
1
EC50 = 6633 nM
   TI
   LI
   LO
   TS
2
Ki = 55 nM
   TI
   LI
   LO
   TS
CP0504852
(2S)-2-acetamido-N-[(2S)-1-[[(1R)-1-[5-[(1R)-1-[(2-hydroxyacetyl)amino]-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide
   Show/Hide
C46H57N9O6
 1
1
Ki = 3 nM
   TI
   LI
   LO
   TS